Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Batch documentation: see Lab Reports / COAs for posted analytical records
The FDA enforcement-discretion period that allowed mass compounding during the tirzepatide shortage ended on March 19, 2025 for 503B outsourcing facilities and February 18, 2025 for 503A pharmacies
These include the peptides quantity, the target concentration required for the study, and the precision needed for laboratory measurements
Monitor Progress: Regular check-ups will help monitor your response to the treatment
US$ 26.87
US$ 21.58
US$ 23.32
US$ 23.78
US$ 28.50
US$ 26.41
